Rare diseases
Investigational molecules
Locations
703 conditions with trials, the busiest first
3 898 trials across Europe, recruiting first
Study on Pembrolizumab for Patients with Localized Non-Metastatic MSI/dMMR Tumors or EBV+ Gastric Cancer
FranceStudy Comparing Tusamitamab Ravtansine and Docetaxel for Patients with Previously Treated Metastatic Non-Small Cell Lung Cancer with CEACAM5-Positive Tumors
FranceStudy of platinum, pemetrexed, atezolizumab and bevacizumab combination in patients with advanced non-small cell lung cancer who have EGFR, ALK or ROS1 mutations and progressed after targeted therapy
FranceStudy of three different doses of busulfan with fludarabine and thymoglobuline in stem cell transplantation for patients with high-risk myeloid blood disorders
FranceStudy on the Safety and Effectiveness of Patritumab Deruxtecan for Patients with Colorectal, Biliary Tract, and Liver Cancer
FranceStudy on WT1 LAMP mRNA DC and Temozolomide for Patients with Newly Diagnosed Glioblastoma
BelgiumStudy Comparing Ensartinib and Crizotinib for Patients with ALK-Positive Non-Small Cell Lung Cancer
BelgiumStudy on Molidustat and Ivosidenib for Adults with Relapsed or Refractory IDH1-Mutated Acute Myeloid Leukemia or Myelodysplastic Syndrome
GermanyStudy on Daratumumab, Lenalidomide, and Dexamethasone for Patients with Primary Plasma Cell Leukemia
FranceSafety Study of 5-Aminolevulinic Acid for Brain Tumor Surgery in Children and Adolescents
GermanyStudy on the Safety and Effectiveness of Fianlimab, Cemiplimab, and Chemotherapy in Adults with Resectable Non-Small Cell Lung Cancer
FranceStudy on De-escalated Induction Therapy with Methotrexate, Cytarabine, Thiotepa, and Rituximab for Newly Diagnosed Primary CNS Lymphoma Patients
AustriaThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
